We are live on ! Find out more
AEMD icon

Aethlon Medical
AEMD

20 hedge funds and large institutions have $388K invested in Aethlon Medical in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more capital invested

Capital invested by funds: $355K → $388K (+$32.7K)

0% less ownership

Funds ownership: 0% → 0% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

13% less funds holding

Funds holding: 23 → 20 (-3)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
20
Holders Change
-3
Holders Change %
-13.04%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
3
Closed
6
Calls
$13K
Puts
–
Net Calls
+$13K
Net Calls Change
+$2K

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
+$41.4K
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$16.9K
3
N
Natixis
France
+$9.41K
4
TSS
Two Sigma Securities
New York
+$9.41K
5
UBS Group
UBS Group
Switzerland
+$5.65K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$38.6K
2
Renaissance Technologies
Renaissance Technologies
New York
-$28K
3
VF
Virtu Financial
New York
-$17K
4
E
Ergoteles
New York
-$13.9K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$13.3K

AEMD Hedge Fund Activity: Q1 2023 in Review

20 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2023, worth a combined $388K — up 9.2% from $355K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of AEMD and 4 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 3 added.

The largest buyer was Two Sigma Investments, adding an estimated $41.4K. The largest seller was Jane Street, exiting entirely with an estimated $38.6K sold.

  • 20 institutional investors held Aethlon Medical (AEMD) as of Q1 2023, down from 23 in Q4 2022.
  • Funds reported $388K of Aethlon Medical stock for Q1 2023, up 9.2% quarter-over-quarter.
  • 4 funds opened new Aethlon Medical positions in Q1 2023 and 6 closed out, a net change of -2 holders.
  • The largest Aethlon Medical buyer in Q1 2023 was Two Sigma Investments, an estimated $41.4K added.
  • The largest Aethlon Medical seller in Q1 2023 was Jane Street, an estimated $38.6K sold.

Based on aggregated 13F filings for Q1 2023.